Download Free Sample
Buy Now
Table of Contents
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5.1. Chapter Overview
5.2. Executive Summary: Market Landscape
5.3. Executive Summary: Market Trends
5.4. Executive Summary: Market Forecast and Opportunity Analysis
6.1. Chapter Overview
6.2. Types of Expression Systems
6.2.1. Microbial Expression Systems
6.2.1.1. Bacterial Expression Systems
6.2.1.2. Fungal Expression Systems
6.2.1.3. Yeast Expression Systems
6.2.2. Mammalian versus Microbial Expression Systems
6.3. Stages of the Microbial Manufacturing Process
6.3.1. Cell Banking
6.3.2. Upstream Bioprocessing
6.3.3. Downstream Bioprocessing
6.4. Overview of Contract Manufacturing
6.5. Need for Outsourcing Microbial Manufacturing
6.6. Commonly Outsourced Manufacturing Operations in Microbial Contract Manufacturing Industry
6.7. Advantages and Disadvantages Associated with Outsourcing Manufacturing Services
6.8. Key Considerations While Selecting a CMO Partner
7.1. Chapter Overview
7.2. Microbial Fermentation Contract Manufacturers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Number and Location of Microbial Fermentation Facilities
7.2.5. Analysis by Compliance
7.2.6. Analysis by Type of Microbial Fermentation Service Offered
7.2.7. Analysis by Type of Microbial Expression System Used
7.2.8. Analysis by Type of Biologic Manufactured
7.2.9. Analysis by Type of Fermenter
7.2.10. Analysis by Scale of Operation
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Microbial Fermentation Contract Manufacturers: Company Competitiveness Analysis
8.4.1. Microbial Fermentation Contract Manufacturers Headquartered in North America (Peer Group I)
8.4.2. Microbial Fermentation Contract Manufacturers Headquartered in Europe (Peer Group II)
8.4.3. Microbial Fermentation Contract Manufacturers Headquartered in Asia-Pacific and Rest of the World (Peer Group III)
9.1. Chapter Overview
9.2. Microbial Fermentation Contract Manufacturers Headquartered in North America
9.2.1. AbbVie*
9.2.1.1. Company Overview
9.2.1.2. Service Portfolio
* Similar details are presented for other companies mentioned below (based on information in the public domain)
9.2.2. AGC Biologics
9.2.3. BioVectra
9.2.4. BOC Sciences
9.2.5. FUJIFILM Biotechnologies
9.2.6. KBI Biopharma
9.3. Microbial Fermentation Contract Manufacturers Headquartered in Europe
9.3.1. Boehringer Ingelheim
9.3.1.1. Company Overview
9.3.1.2. Service Portfolio
9.3.2. Eurofins Scientific
9.3.3. Evonik Health Care
9.3.4. Lonza
9.3.5. Novartis
9.3.6. Sandoz
9.4. Microbial Fermentation Contract Manufacturers Headquartered in Asia-Pacific
9.4.1. BioCina
9.4.1.1. Company Overview
9.4.1.2. Service Portfolio
9.4.2. Biocon Biologics
9.4.3. OneSource Specialty Pharma
9.4.4. WuXi Biologics
10.1. Chapter Overview
10.2. Partnership Models
10.3. Microbial Fermentation Contract Manufacturers: Partnerships and Collaborations
10.3.1. Cumulative Trend of Partnerships, Since 2020
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Type of Partner
10.3.5. Analysis by Type of Biologic Manufactured
10.3.6. Analysis by Scale of Operation
10.3.7. Most Active Players: Analysis by Number of Partnerships
10.3.8. Analysis by Geography
10.3.8.1. Local and International Agreements
10.3.8.2. Intracontinental and Intercontinental Agreements
11.1. Chapter Overview
11.2. Type of Expansions
11.3. Microbial Fermentation Contract Manufacturers: Recent Expansions
11.3.1. Analysis by Year of Expansion
11.3.2. Analysis by Type of Expansion
11.3.3. Analysis by Year and Type of Expansion
11.3.4. Analysis by Microbial Fermentation Capacity
11.3.5. Analysis by Type of Biologic Manufactured
11.3.6. Analysis by Location of Expanded Facility
11.3.7. Analysis by Type of Expansion and Location of Expanded Facility
11.3.8. Geographical Analysis
11.3.8.1. Analysis by Region
11.3.8.2. Analysis by Country
12.1. Chapter Overview
12.2. Microbial Fermentation Contract Manufacturers: Initiatives Undertaken by Big Pharma Players
12.2.1. Analysis by Number of Initiatives
12.2.2. Analysis by Year of Initiative
12.2.3. Analysis by Company and Year of Initiative
12.2.4. Analysis by Purpose of Initiative
12.2.5. Analysis by Company and Purpose of Initiative
12.2.6. Analysis by Type of Initiative
12.2.7. Analysis by Scale of Operation
12.2.8. Analysis by Type of Drug Molecule
12.2.9. Analysis by Type of Microbial Expression System Used
12.2.10. Geographical Analysis by Investment Made
12.2.11. Competitive Benchmarking of Big Pharmaceutical Players
13.1. Chapter Overview
13.2. AC Matrix: Overview
13.2.1. Strong Business Segments
13.2.2. Average Business Segments
13.2.3. Weak Business Segments
13.3. AC Matrix: Analytical Methodology
13.4. AC Matrix: Microbial Contract Manufacturing Scenario in North America
13.5. AC Matrix: Microbial Contract Manufacturing Scenario in Europe
13.6. AC Matrix: Microbial Contract Manufacturing Scenario in Asia-Pacific
14.1. Chapter Overview
14.2. Assumptions and Parameter Definitions
14.2.1. Scenario 1
14.2.2. Scenario 2
14.2.3. Scenario 3
14.2.4. Scenario 4
14.3. Concluding Remarks
15.1. Chapter Overview
15.2. Technology Platforms Commonly Used for Microbial Fermentation
15.3. Outline of Single Use Technologies
15.4. Concluding Remarks
16.1. Chapter Overview
16.2. Small Molecule and Large Molecule Drugs / Therapies
16.2.1. Comparison of Key Characteristics
16.2.2. Comparison of Microbial Manufacturing Process
16.2.2.1. Microbial Contract Manufacturers Providing Services for Small Molecules
16.2.3. Comparison of Key Manufacturing-related Challenges
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Biopharmaceutical Contract Manufacturing: Global Installed Capacity
17.3.1. Analysis by Company Size
17.3.2. Analysis by Type of Expression System Used
17.3.3. Analysis by Geography
17.3.3.1. Analysis of Biopharmaceutical Contract Manufacturing Capacity in North America
17.3.3.2. Analysis of Biopharmaceutical Contract Manufacturing Capacity in Europe
17.3.3.3. Analysis of Biopharmaceutical Contract Manufacturing Capacity in Asia-Pacific
17.3.3.4. Analysis of Biopharmaceutical Contract Manufacturing Capacity in Rest of the World
17.4. Concluding Remarks
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Global Demand for Biopharmaceutical Contract Manufacturing
18.4. Global Demand for Biopharmaceutical Contract Manufacturing: Analysis by Scale of Operation
18.5. Global Demand for Biopharmaceutical Contract Manufacturing: Analysis by Type of Expression System Used
18.6. Global Demand for Emerging Novel Biologics
18.6.1. Global Demand for ADC Therapeutics
18.6.2. Global Demand for Cell Therapy Manufacturing
19.1. Chapter Overview
19.2. Market Drivers
19.3. Market Restraints
19.4. Market Opportunities
19.5. Market Challenges
19.6. Conclusion
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Global Microbial Fermentation CMO Market, Historical Trends (since 2022) and Forecasted Estimates (till 2035)
20.3.1. Roots Analysis Perspective on Market Growth
20.3.2. Scenario Analysis
20.3.2.1. Conservative Scenario
20.3.2.2. Optimistic Scenario
20.4. Key Market Segmentations
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Microbial Fermentation CMO Market: Distribution by Type of Expression System
21.3.1. Bacterial Expression Systems: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
21.3.2. Yeast Expression Systems: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
21.3.3. Other Expression Systems: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
21.4. Data Triangulation and Validation
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Microbial Fermentation CMO Market: Distribution by Type of Biologic Manufactured
22.3.1. Recombinant Proteins: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
22.3.2. Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
22.3.3. Enzymes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
22.3.4. Plasmid DNA: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
22.3.5. Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
22.4. Data Triangulation and Validation
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Microbial Fermentation CMO Market: Distribution by Company Size
23.3.1. Small Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
23.3.2. Mid-sized Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
23.3.3. Large and Very Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
23.4. Data Triangulation and Validation
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Microbial Fermentation CMO Market: Distribution by End User
24.3.1. Pharmaceutical and Biotechnological Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
24.3.2. Academic and Research Institutes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
24.4. Data Triangulation and Validation
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Microbial Fermentation CMO Market: Distribution by Geographical Regions
25.3.1. North America: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.1.1. US: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.1.2. Canada: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.1.3. Puerto Rico: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2. Europe: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2.1. Germany: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2.2. UK: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2.3. France: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2.4. Spain: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2.5. Italy: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.2.6. Rest of Europe: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.3. Asia-Pacific: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.3.1. China: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.3.2. South Korea: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.3.3. Japan: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.3.4. Singapore: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.3.5. Rest of Asia-Pacific: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.4. Rest of the World: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.4.1. Israel: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.4.2. Argentina: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.3.4.3. Africa: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
25.4. Market Dynamics Assessment
25.4.1. Market Movement Analysis
25.4.2. Penetration-Growth (P-G) Matrix
25.5. Data Triangulation and Validation
26.1. Microbial Fermentation CMO Market in North America: Distribution by Type of Biologic Manufactured
26.1.1. Microbial Fermentation CMO Market in North America for Recombinant Proteins: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.1.2. Microbial Fermentation CMO Market in North America for Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.1.3. Microbial Fermentation CMO Market in North America for Enzymes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.1.4. Microbial Fermentation CMO Market in North America for Plasmid DNA: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.1.5. Microbial Fermentation CMO Market in North America for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.2. Microbial Fermentation CMO Market in North America: Distribution by Company Size
26.2.1. Microbial Fermentation CMO Market in North America for Small Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.2.2. Microbial Fermentation CMO Market in North America for Mid-sized Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.2.3. Microbial Fermentation CMO Market in North America for Large and Very Large Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.3. Microbial Fermentation CMO Market in North America: Distribution by End User
26.3.1. Microbial Fermentation CMO Market in North America for Pharmaceutical and Biotechnological Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
26.3.2. Microbial Fermentation CMO Market in North America for Academic and Research Institutes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.1. Microbial Fermentation CMO Market in Europe: Distribution by Type of Biologic Manufactured
27.1.1. Microbial Fermentation CMO Market in Europe for Recombinant Proteins: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.1.2. Microbial Fermentation CMO Market in Europe for Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.1.3. Microbial Fermentation CMO Market in Europe for Enzymes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.1.4. Microbial Fermentation CMO Market in Europe for Plasmid DNA: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.1.5. Microbial Fermentation CMO Market in Europe for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.2. Microbial Fermentation CMO Market in Europe: Distribution by Company Size
27.2.1. Microbial Fermentation CMO Market in Europe for Small Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.2.2. Microbial Fermentation CMO Market in Europe for Mid-sized Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.2.3. Microbial Fermentation CMO Market in Europe for Large and Very Large Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.3. Microbial Fermentation CMO Market in Europe: Distribution by End User
27.3.1. Microbial Fermentation CMO Market in Europe for Pharmaceutical and Biotechnological Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
27.3.2. Microbial Fermentation CMO Market in Europe for Academic and Research Institutes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.1. Microbial Fermentation CMO Market in Asia-Pacific: Distribution by Type of Biologic Manufactured
28.1.1. Microbial Fermentation CMO Market in Asia-Pacific for Recombinant Proteins: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.1.2. Microbial Fermentation CMO Market in Asia-Pacific for Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.1.3. Microbial Fermentation CMO Market in Asia-Pacific for Enzymes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.1.4. Microbial Fermentation CMO Market in Asia-Pacific for Plasmid DNA: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.1.5. Microbial Fermentation CMO Market in Asia-Pacific for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.2. Microbial Fermentation CMO Market in Asia-Pacific: Distribution by Company Size
28.2.1. Microbial Fermentation CMO Market in Asia-Pacific for Small Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.2.2. Microbial Fermentation CMO Market in Asia-Pacific for Mid-sized Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.2.3. Microbial Fermentation CMO Market in Asia-Pacific for Large and Very Large Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.3. Microbial Fermentation CMO Market in Asia-Pacific: Distribution by End User
28.3.1. Microbial Fermentation CMO Market in Asia-Pacific for Pharmaceutical and Biotechnological Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
28.3.2. Microbial Fermentation CMO Market in Asia-Pacific for Academic and Research Institutes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.1. Microbial Fermentation CMO Market in Rest of the World: Distribution by Type of Biologic Manufactured
29.1.1. Microbial Fermentation CMO Market in Rest of the World for Recombinant Proteins: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.1.2. Microbial Fermentation CMO Market in Rest of the World for Antibodies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.1.3. Microbial Fermentation CMO Market in Rest of the World for Enzymes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.1.4. Microbial Fermentation CMO Market in Rest of the World for Plasmid DNA: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.1.5. Microbial Fermentation CMO Market in Rest of the World for Other Biologics: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.2. Microbial Fermentation CMO Market in Rest of the World: Distribution by Company Size
29.2.1. Microbial Fermentation CMO Market in Rest of the World for Small Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.2.2. Microbial Fermentation CMO Market in Rest of the World for Mid-sized Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.2.3. Microbial Fermentation CMO Market in Rest of the World for Large and Very Large Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.3. Microbial Fermentation CMO Market in Rest of the World: Distribution by End User
29.3.1. Microbial Fermentation CMO Market in Rest of the World for Pharmaceutical and Biotechnological Companies: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
29.3.2. Microbial Fermentation CMO Market in Rest of the World for Academic and Research Institutes: Historical Trends (since 2022) and Forecasted Estimates (till 2035)
**Detailed information on Chapters 26-29 is available in the Excel Data Packs shared along with the report**
31.1. Chapter Overview
31.2. Company A
31.2.1. Company Snapshot
31.2.2. Interview Transcript: Chief Executive Officer and Managing Director
31.3. Company B
31.3.1. Company Snapshot
31.3.2. Interview Transcript: Vice President, Sales and Marketing
31.4. Company C
31.4.1. Company Snapshot
31.4.2. Interview Transcript: Vice President, Business Development
31.5. Company D
31.5.1. Company Snapshot
31.5.2. Interview Transcript: Business Development and Marketing Manager
31.6. Company E
31.6.1. Company Snapshot
31.6.2. Interview Transcript: Business Development Manager
31.7. Company F
31.7.1. Company Snapshot
31.7.2. Interview Transcript: Business Development Manager
31.8. Company G
31.8.1. Company Snapshot
31.8.2. Interview Transcript: Former Vice President, Sales and Business Development
31.9. Company H
31.9.1. Company Snapshot
31.9.2. Interview Transcript: Former General Manager, Business Development
List of Figures
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 2.3 Research Methodology: Robust Quality Control
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Market Assessment Framework
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Market Landscape
Figure 5.2 Executive Summary: Market Trends (I / II)
Figure 5.3 Executive Summary: Market Trends (II / II)
Figure 5.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 6.1 Types of Expression Systems
Figure 6.2 Stages of the Microbial Manufacturing Process
Figure 6.3 Overview of Cell Bank Systems
Figure 6.4 Types of Third-Party Service Providers
Figure 6.5 Commonly Outsourced Microbial Contract Biomanufacturing Operations
Figure 6.6 Advantages and Disadvantages Associated with Outsourcing Manufacturing Services
Figure 7.1 Microbial Fermentation Contract Manufacturers: Distribution by Year of Establishment
Figure 7.2 Microbial Fermentation Contract Manufacturers: Distribution by Company Size
Figure 7.3 Microbial Fermentation Contract Manufacturers: Distribution by Location of Headquarters
Figure 7.4 Microbial Fermentation Contract Manufacturers: Distribution by Number and Location of Microbial Fermentation Facilities
Figure 7.5 Microbial Fermentation Contract Manufacturers: Distribution by Compliance
Figure 7.6 Microbial Fermentation Contract Manufacturers: Distribution by Type of Microbial Fermentation Service Offered
Figure 7.7 Microbial Fermentation Contract Manufacturers: Distribution by Type of Microbial Expression System Used
Figure 7.8 Microbial Fermentation Contract Manufacturers: Distribution by Type of Biologic Manufactured
Figure 7.9 Microbial Fermentation Contract Manufacturers: Distribution by Type of Fermenter
Figure 7.10 Microbial Fermentation Contract Manufacturers: Distribution by Scale of Operation
Figure 8.4 Company Competitiveness Analysis: Microbial Fermentation Contract Manufacturers based in North America (Peer Group I)
Figure 8.5 Company Competitiveness Analysis: Microbial Fermentation Contract Manufacturers based in Europe (Peer Group II)
Figure 8.6 Company Competitiveness Analysis: Microbial Fermentation Contract Manufacturers based in Asia-Pacific (Peer Group III)
Figure 10.1 Partnerships and Collaborations: Cumulative Trend of Partnerships, Since 2020
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.5 Partnerships and Collaborations: Distribution by Type of Biologic Manufactured
Figure 10.6 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 10.7 Most Active Players: Distribution by Number of Partnerships
Figure 10.8 Partnerships and Collaborations: Local and International Agreements
Figure 10.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 11.1 Recent Expansions: Distribution by Year of Expansion
Figure 11.2 Recent Expansions: Distribution by Type of Expansion
Figure 11.3 Recent Expansions: Distribution by Year and Type of Expansion
Figure 11.4 Recent Expansions: Distribution by Microbial Fermentation Capacity
Figure 11.5 Recent Expansions: Distribution by Type of Biologic Manufactured
Figure 11.6 Recent Expansions: Distribution by Location of Expanded Facility
Figure 11.7 Recent Expansions: Distribution by Type of Expansion and Location of Expanded Facility
Figure 11.8 Recent Expansions: Distribution by Location of Expanded Facility (Region)
Figure 11.9 Recent Expansions: Distribution by Location of Expanded Facility (Country)
Figure 12.1 Big Pharma Players: Distribution by Number of Microbial Biopharmaceutical Manufacturing Focused Initiatives
Figure 12.2 Big Pharma Players: Cumulative Distribution by Year of Initiative
Figure 12.3 Big Pharma Players: Distribution by Company and Year of Initiative
Figure 12.4 Big Pharma Players: Distribution by Purpose of Initiative
Figure 12.5 Big Pharma Players: Distribution by Company and Purpose of Initiative
Figure 12.6 Big Pharma Players: Distribution by Type of Initiative
Figure 12.7 Big Pharma Players: Distribution by Scale of Operation
Figure 12.8 Big Pharma Players: Distribution by Type of Drug Molecule
Figure 12.9 Big Pharma Players: Distribution by Type of Biologic Manufactured
Figure 12.10 Big Pharma Players: Distribution by Type of Microbial Expression System Used
Figure 12.11 Big Pharma Players: Distribution by Location of Initiative
Figure 12.12 Big Pharma Players: Distribution by Company and Location of Initiative
Figure 12.13 Harvey Ball Analysis: Big Pharma Investment Summary
Figure 13.1 Attractiveness Competition Matrix: Pictorial Representation
Figure 13.2 Attractiveness Competition Matrix: Positioning of Different Biologics in North America
Figure 13.3 Attractiveness Competition Matrix: Positioning of Different Biologics in Europe
Figure 13.4 Attractiveness Competition Matrix: Positioning of Different Biologics in Asia-Pacific
Figure 14.1 Make versus Buy Decision Making Framework
Figure 14.2 Make versus Buy Decision Making: Possible Scenario Descriptions
Figure 15.1 Fermentation Technology / Platform: Distribution by Type of Microbial Expression System Used
Figure 15.2 Fermentation Technology / Platform: Distribution by Application
Figure 16.1 Small Molecules versus Large Molecules: Comparison of Key Characteristics
Figure 16.2 Small Molecules versus Large Molecule: Comparison of Manufacturing Process
Figure 16.3 Microbial Contract Manufacturing: Distribution by Type of Product
Figure 16.4 Microbial Contract Manufacturing: Distribution by Type of Microbial Expression System Used
Figure 17.1 Global Capacity of Biopharmaceutical Contract Manufacturers (in liters): Distribution by Company Size
Figure 17.2 Global Capacity of Biopharmaceutical Contract Manufacturers (in liters): Distribution by Type of Expression System Used
Figure 17.3 Global Capacity of Biopharmaceutical Contract Manufacturers (in liters): Distribution by Geography
Figure 17.4 Biopharmaceutical Contract Manufacturing Capacity in North America
Figure 17.5 Biopharmaceutical Contract Manufacturing Capacity in Europe
Figure 17.6 Biopharmaceutical Contract Manufacturing Capacity in Asia-Pacific
Figure 17.7 Capacity Analysis: Biopharmaceutical Contract Manufacturing Capacity in Rest of the World
Figure 18.1 Global Demand for Biopharmaceutical Contract Manufacturing, Historical Trends (Since 2024) and Forecasted Estimates (Till 2035) (in million liters)
Figure 18.2 Global Demand for Biopharmaceutical Contract Manufacturing: Distribution by Scale of Operation, Historical Trends (Since 2024) and Forecasted Estimates (Till 2035) (in million liters)
Figure 18.3 Global Demand for Biopharmaceutical Contract Manufacturing: Distribution by Type of Expression System Used, Historical Trends (Since 2024) and Forecasted Estimates (Till 2035) (in million liters)
Figure 18.4 Global Demand for ADC Therapeutics, Historical Trends (Since 2024) and Forecasted Estimates (till 2035) (in kilograms)
Figure 18.5 Global Demand for Cell Therapy Manufacturing, Historical Trends (since 2024) and Forecasted Estimates (till 2035) (in terms of Number of Patients)
Figure 18.6 Global Demand for Cell Therapy Manufacturing, Historical Trends (since 2024) and Forecasted Estimates (till 2035) (in terms of Number of Cells in Billion)
Figure 20.1 Global Microbial Fermentation CMO Market, Historical Trends (since 2022) and Forecasted Estimated (till 2035) (USD Million)
Figure 20.2 Global Microbial Fermentation CMO Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Million)
Figure 20.3 Global Microbial Fermentation CMO Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Million)
Figure 21.1 Microbial Fermentation CMO Market: Distribution by Type of Expression System
Figure 21.2 Microbial Fermentation CMO Market for Bacterial Expression Systems, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 21.3 Microbial Fermentation CMO Market for Yeast Expression Systems, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 21.4 Microbial Fermentation CMO Market for Other Expression Systems, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 22.1 Microbial Fermentation CMO Market: Distribution by Type of Biologic Manufactured
Figure 22.2 Microbial Fermentation CMO Market for Recombinant Proteins, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 22.3 Microbial Fermentation CMO Market for Enzymes, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 22.4 Microbial Fermentation CMO Market for Plasmid DNA, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 22.5 Microbial Fermentation CMO Market for Antibodies, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 22.6 Microbial Fermentation CMO Market for Other Biologics, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 23.1 Microbial Fermentation CMO Market: Distribution by Company Size
Figure 23.2 Microbial Fermentation CMO Market for Small Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 23.3 Microbial Fermentation CMO Market for Mid-sized Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 23.4 Microbial Fermentation CMO Market for Large and Very Large Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 24.1 Microbial Fermentation CMO Market: Distribution by End User
Figure 24.2 Microbial Fermentation CMO Market for Pharmaceutical and Biotechnological Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 24.3 Microbial Fermentation CMO Market for Academic and Research Institutes, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.1 Microbial Fermentation CMO Market: Distribution by Geographical Regions
Figure 25.2 Microbial Fermentation CMO Market in North America, Historical Trends (since 2022) and Forecasted Estimates (till 2035)
Figure 25.3 Microbial Fermentation CMO Market in the US, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.4 Microbial Fermentation CMO Market in Canada, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.5 Microbial Fermentation CMO Market in Puerto Rico, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.6 Microbial Fermentation CMO Market in Europe, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.7 Microbial Fermentation CMO Market in Germany, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.8 Microbial Fermentation CMO Market in the UK, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.9 Microbial Fermentation CMO Market in France, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.10 Microbial Fermentation CMO Market in Spain, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.11 Microbial Fermentation CMO Market in Italy, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.12 Microbial Fermentation CMO Market in Rest of Europe, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.13 Microbial Fermentation CMO Market in Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.14 Microbial Fermentation CMO Market in China, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.15 Microbial Fermentation CMO Market in South Korea, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.16 Microbial Fermentation CMO Market in Japan, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.17 Microbial Fermentation CMO Market in Singapore, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.18 Microbial Fermentation CMO Market in Rest of Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.19 Microbial Fermentation CMO Market in Rest of the World, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.20 Microbial Fermentation CMO Market in Israel, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.21 Microbial Fermentation CMO Market in Argentina, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 25.22 Microbial Fermentation CMO Market in Africa, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Million)
Figure 30.1 Concluding Remarks: Overall Market Landscape
Figure 30.2 Concluding Remarks: Partnerships and Collaborations
Figure 30.3 Concluding Remarks: Recent Expansions
Figure 30.4 Concluding Remarks: Market Forecast and Opportunity Analysis
List of Tables
Table 6.1 Mammalian versus Microbial Expression Systems
Table 7.1 Microbial Fermentation Contract Manufacturers: Information on Year of Establishment, Company Size, Location of Headquarters, Number and Location of Facilities
Table 7.2 Microbial Fermentation Contract Manufacturers: Information on Compliance and Microbial Fermentation Service Offered
Table 7.3 Microbial Fermentation Contract Manufacturers: Information on Type of Microbial Expression System Used and Biologic Manufactured
Table 7.4 Microbial Fermentation Contract Manufacturers: Information on Type of Fermenter and Scale of Operation
Table 8.1 Company Competitiveness Analysis: Microbial Fermentation Contract Manufacturers based in North America
Table 8.2 Company Competitiveness Analysis: Microbial Fermentation Contract Manufacturers based in Europe
Table 8.3 Company Competitiveness Analysis: Microbial Fermentation Contract Manufacturers based in Asia-Pacific and Rest of the World
Table 9.1 Microbial Fermentation Contract Manufacturers: List of Companies Profiled
Table 9.2 AbbVie: Company Overview
Table 9.3 AbbVie: Service Portfolio
Table 9.4 AGC Biologics: Company Overview
Table 9.5 AGC Biologics: Service Portfolio
Table 9.6 BioVectra: Company Overview
Table 9.7 BioVectra: Service Portfolio
Table 9.8 FUJIFILM Biotechnologies: Company Overview
Table 9.9 FUJIFILM Biotechnologies: Service Portfolio
Table 9.10 KBI Biopharma: Company Overview
Table 9.11 KBI Biopharma: Service Portfolio
Table 9.12 Boehringer Ingelheim: Company Overview
Table 9.13 Boehringer Ingelheim: Service Portfolio
Table 9.14 Eurofins Scientific: Company Overview
Table 9.15 Eurofins Scientific: Service Portfolio
Table 9.16 Evonik Health Care: Company Overview
Table 9.17 Evonik Health Care: Service Portfolio
Table 9.18 Lonza: Company Overview
Table 9.19 Lonza: Service Portfolio
Table 9.20 Novartis: Company Overview
Table 9.21 Novartis: Service Portfolio
Table 9.22 Sandoz: Company Overview
Table 9.23 Sandoz: Service Portfolio
Table 9.24 BioCina: Company Overview
Table 9.25 BioCina: Service Portfolio
Table 9.26 Biocon Biologics: Company Overview
Table 9.27 Biocon Biologics: Service Portfolio
Table 9.28 OneSource Specialty Pharma: Company Overview
Table 9.29 OneSource Specialty Pharma: Service Portfolio
Table 9.30 WuXi Biologics: Company Overview
Table 9.31 WuXi Biologics: Service Portfolio
Table 10.1 Microbial Fermentation Contract Manufacturers: List of Partnerships and Collaborations
Table 10.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement
Table 11.1 Microbial Fermentation Contract Manufacturers: List of Recent Expansions
Table 12.1 Big Pharmaceutical Players: List of Initiatives
Table 15.1 List of Technology Platforms for Microbial Manufacturing
Table 16.1 List of Microbial Contract Manufacturers
Table 16.2 Small Molecules and Large Molecules: Comparison of Development Characteristics
Table 17.1 Biopharmaceutical Contract Manufacturers: Information on Mammalian and Microbial Production Capacities (Sample Dataset)
Table 17.2 Biopharmaceutical Contract Manufacturing: Average Mammalian and Microbial Production Capacity Based on Company Size
Table 17.3 Biopharmaceutical Contract Manufacturers: Information on Production Capacity (Sample Dataset)
Table 17.4 Biopharmaceutical Contract Manufacturing: Average Production Capacity Based on Company Size (Sample Dataset)
Table 17.5 Global Biopharmaceutical Contract Manufacturing Capacity: Distribution by Company Size (in liters)
Table 19.1 Growth Drivers: Market Impact and Time Period
Table 19.2 Growth Restraints: Market Impact and Time Period
Table 19.3 Growth Opportunities: Market Impact and Time Period
Table 19.4 Growth Challenges: Market Impact and Time Period
Table 31.1 Company A: Company Snapshot
Table 31.2 Company B: Company Snapshot
Table 31.3 Company C: Company Snapshot
Table 31.4 Company D: Company Snapshot
Table 31.5 Company E: Company Snapshot
Table 31.6 Company F: Company Snapshot
Table 31.7 Company G: Company Snapshot
Table 31.8 Company H: Company Snapshot
Table 33.1 Microbial Fermentation Contract Manufacturers: Distribution by Year of Establishment
Table 33.2 Microbial Fermentation Contract Manufacturers: Distribution by Company Size
Table 33.3 Microbial Fermentation Contract Manufacturers: Distribution by Location of Headquarters
Table 33.4 Microbial Fermentation Contract Manufacturers: Distribution by Number and Location of Microbial Fermentation Facilities
Table 33.5 Microbial Fermentation Contract Manufacturers: Distribution by Compliance
Table 33.6 Microbial Fermentation Contract Manufacturers: Distribution by Type of Microbial Service Offered
Table 33.7 Microbial Fermentation Contract Manufacturers: Distribution by Type of Microbial Expression System Used
Table 33.8 Microbial Fermentation Contract Manufacturers: Distribution by Type of Biologic Manufactured
Table 33.9 Microbial Fermentation Contract Manufacturers: Distribution by Type of Fermenter
Table 33.10 Microbial Fermentation Contract Manufacturers: Distribution by Scale of Operation
Table 33.11 Partnerships and Collaborations: Distribution by Year of Partnership
Table 33.12 Partnerships and Collaborations: Distribution by Type of Partnership
Table 33.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 33.14 Partnerships and Collaborations: Distribution by Type of Partner
Table 33.15 Partnerships and Collaborations: Distribution by Type of Biologic Manufactured
Table 33.16 Partnerships and Collaborations: Distribution by Scale of Operation
Table 33.17 Most Active Players: Analysis by Number of Partnerships
Table 33.18 Partnerships and Collaborations: Local and International Agreements
Table 33.19 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 33.20 Recent Expansions: Distribution by Year of Expansion
Table 33.21 Recent Expansions: Distribution by Type of Expansion
Table 33.22 Recent Expansions: Distribution by Year and Type of Expansion
Table 33.23 Recent Expansions: Distribution by Microbial Fermentation Capacity
Table 33.24 Recent Expansions: Distribution by Type of Biologic Manufactured
Table 33.25 Recent Expansions: Distribution by Location of Expanded Facility
Table 33.26 Recent Expansions: Distribution by Type of Expansion and Location of Expanded Facility
Table 33.27 Recent Expansions: Distribution by Location of Expanded Facility (Region)
Table 33.28 Recent Expansions: Distribution by Location of Expanded Facility (Country)
Table 33.29 Big Pharma Players: Distribution by Number of Initiatives
Table 33.30 Big Pharma Players: Distribution by Year of Initiative
Table 33.31 Big Pharma Players: Distribution by Company and Year of Initiative
Table 33.32 Big Pharma Players: Distribution by Purpose of Initiative
Table 33.33 Big Pharma Players: Distribution by Company and Purpose of Initiative
Table 33.34 Big Pharma Players: Distribution by Type of Initiative
Table 33.35 Big Pharma Players: Distribution by Scale of Operation
Table 33.36 Big Pharma Players: Distribution by Type of Drug Molecule
Table 33.37 Big Pharma Players: Distribution by Company and Type of Biologic Manufactured
Table 33.38 Big Pharma Players: Distribution by Type of Microbial Expression System Used
Table 33.39 Big Pharma Players: Distribution by Location of Initiative
Table 33.40 Big Pharma Players: Distribution by Company and Location of Initiative
Table 33.41 Microbial Fermentation Technology / Platform: Distribution by Type of Microbial Expression System Used
Table 33.42 Microbial Fermentation Technology / Platform: Distribution by Application
Table 33.43 Global Capacity of Biopharmaceutical Contract Manufacturers (in liters): Distribution by Company Size
Table 33.44 Global Capacity of Biopharmaceutical Contract Manufacturers (in liters): Distribution by Type of Expression System Used
Table 33.45 Global Capacity of Biopharmaceutical Contract Manufacturers (in liters): Distribution by Geography
Table 33.46 Biopharmaceutical Contract Manufacturing Capacity in North America
Table 33.47 Biopharmaceutical Contract Manufacturing Capacity in Europe
Table 33.48 Biopharmaceutical Contract Manufacturing Capacity in Asia-Pacific
Table 33.49 Capacity Analysis: Biopharmaceutical Contract Manufacturing Capacity in Rest of the World
Table 33.50 Global Demand for Biopharmaceutical Contract Manufacturing, Historical Trends (Since 2024) and Forecasted Estimates (Till 2035) (in million liters)
Table 33.51 Global Demand for Biopharmaceutical Contract Manufacturing: Distribution by Scale of Operation, Historical Trends (Since 2024) and Forecasted Estimates (Till 2035) (in million liters)
Table 33.52 Global Demand for Biopharmaceutical Contract Manufacturing: Distribution by Type of Expression System Used, Historical Trends (Since 2024) and Forecasted Estimates (Till 2035) (in million liters)
Table 33.53 Global Demand for ADC Therapeutics, Historical Trends (Since 2024) and Forecasted Estimates (till 2035) (in kilograms)
Table 33.54 Global Demand for Cell Therapy Manufacturing, Historical Trends (since 2024) and Forecasted Estimates (till 2035) (in terms of Number of Patients)
Table 33.55 Global Demand for Cell Therapy Manufacturing, Historical Trends (since 2024) and Forecasted Estimates (till 2035) (in terms of Number of Cells in Billion)
Table 33.56 Global Microbial Fermentation CMO Market, Historical Trends (since 2022) and Forecasted Estimates (till 2035) (USD Billion)
Table 33.57 Global Microbial Fermentation CMO Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Billion)
Table 33.58 Global Microbial Fermentation CMO Market, Forecasted Estimates (till 2035), Optimistic Scenario (USD Billion)
Table 33.59 Microbial Fermentation CMO Market: Distribution by Type of Expression System
Table 33.60 Microbial Fermentation CMO Market for Bacterial Expression Systems, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.61 Microbial Fermentation CMO Market for Yeast Expression Systems, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.62 Microbial Fermentation CMO Market for Other Expression Systems, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.63 Microbial Fermentation CMO Market: Distribution by Type of Biologic Manufactured
Table 33.64 Microbial Fermentation CMO Market for Recombinant Proteins, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.65 Microbial Fermentation CMO Market for Enzymes, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.66 Microbial Fermentation CMO Market for Plasmid DNA, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.67 Microbial Fermentation CMO Market for Antibodies, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.68 Microbial Fermentation CMO Market for Other Biologics, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.69 Microbial Fermentation CMO Market: Distribution by Company Size
Table 33.70 Microbial Fermentation CMO Market for Small Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.71 Microbial Fermentation CMO Market for Mid-sized Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.72 Microbial Fermentation CMO Market for Large and Very Large Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.73 Microbial Fermentation CMO Market: Distribution by End User
Table 33.74 Microbial Fermentation CMO Market for Pharmaceutical and Biotechnological Companies, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.75 Microbial Fermentation CMO Market for Academic and Research Institutes, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.76 Microbial Fermentation CMO Market: Distribution by Geographical Regions
Table 33.77 Microbial Fermentation CMO Market in North America, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.78 Microbial Fermentation CMO Market in the US, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.79 Microbial Fermentation CMO Market in Canada, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.80 Microbial Fermentation CMO Market in Puerto Rico, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.81 Microbial Fermentation CMO Market in Europe, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.82 Microbial Fermentation CMO Market in Germany, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.83 Microbial Fermentation CMO Market in the UK, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.84 Microbial Fermentation CMO Market in France, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.85 Microbial Fermentation CMO Market in Spain, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.86 Microbial Fermentation CMO Market in Italy, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.87 Microbial Fermentation CMO Market in Rest of Europe, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.88 Microbial Fermentation CMO Market in Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.89 Microbial Fermentation CMO Market in China, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.90 Microbial Fermentation CMO Market in South Korea, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.91 Microbial Fermentation CMO Market in Japan, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.92 Microbial Fermentation CMO Market in Singapore, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.93 Microbial Fermentation CMO Market in Rest of Asia-Pacific, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.94 Microbial Fermentation CMO Market in Rest of the World, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.95 Microbial Fermentation CMO Market in Israel, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.96 Microbial Fermentation CMO Market in Argentina, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)
Table 33.97 Microbial Fermentation CMO Market in Africa, Historical Trends (since 2022) and Forecasted Estimates (till 2035): Conservative, Base and Optimistic Scenario (USD Million)